This article is more than 5 years old. Information may no longer be current.
Top five stories in psoriatic arthritis
Click Here to Manage Email Alerts
Healio Rheumatology presents the five top stories in psoriatic arthritis.
Study: MRI useful in evaluation of patients with PsA
According to a recently published study, MRI can be useful in the evaluation of patients with psoriatic arthritis (PsA). Read More.
European Commission approves Orencia for PsA
The European Commission has approved Bristol Myers-Squibb’s Orencia for patients with active psoriatic arthritis (PsA), according to a company press release. Read More.
Findings support efficacy of abatacept for joint-related results in patients with PsA
Among patients with psoriatic arthritis (PsA), abatacept was associated with a decrease in regulatory T-cell expression, according to a recently published study. Read More.
FDA approves Orencia for PsA
The FDA has approved Orencia for the treatment of patients with active psoriatic arthritis (PsA). It is approved for both subcutaneous and intravenous injections, according to a company press release. Read More.
Study: Fatigue driven by inflammation, disease duration and chronic pain in PsA
MADRID — According to findings presented at the EULAR Annual Congress, fatigue in patients with psoriatic arthritis (PsA) was driven by inflammation, disease duration and chronic pain. Read More.